Editorial: Data mining methods for analyzing cognitive and affective disorders based on multimodal omics, volume II

Tao Wang, Elaine Chapman, zhongyu wei, Jiajie PengFrontiers in Psychiatry 2023 · DOI · OpenAlex

Editorial: Data Mining Methods for Analyzing Cognitive and Affective Disorders Based on Multimodal Omics

Introduction

Cognitive disorders—such as dementia, amnesia, and delirium—and affective disorders—including depression and bipolar disorder—have traditionally been treated as distinct clinical categories. However, modern psychiatric research increasingly reveals that these conditions are deeply intertwined. For instance, chronic depression is now recognized as a significant risk factor for the later development of dementia. Despite these insights, understanding the precise interactions between cognitive and emotional health remains a complex challenge.

This editorial introduces a curated collection of research from Frontiers in Psychiatry that leverages "multimodal omics." By integrating diverse data streams—ranging from genomics and microbiome analysis to real-time behavioral video and EEG signals—these studies aim to move beyond subjective clinical interviews toward objective, data-driven diagnostics and monitoring.

Advanced Computational Methods

The research featured in this volume highlights a shift toward sophisticated machine learning and deep learning architectures designed to handle the complexity of multimodal data:

  • Computer Vision for Behavioral Analysis: Researchers utilized Multi-modal Deep Convolutional Neural Networks (CNNs) to analyze video footage. By extracting facial expressions and body movements, they developed objective metrics for assessing the severity of depression.
  • Cross-Domain Algorithmic Application: In a notable example of "algorithmic transference," the k-mer analysis method—typically used for DNA sequencing—was applied to EEG microstates. This approach significantly improved the accuracy of emotion recognition by treating brainwave patterns as biological sequences.
  • Temporal Speech Processing: Hybrid neural networks, combining CNNs with Long Short-Term Memory (LSTM) layers, were employed to capture the temporal nuances of speech, allowing for more accurate inference of a patient's emotional state.
  • Microbiome-Metabolite Interaction: The LMFLNC (Logical Matrix Factorization and Local Nearest Neighbor Constraints) algorithm was introduced to predict interactions between metabolites and diseases, utilizing heterogeneous microbiome data to identify potential biomarkers.

Key Insights and Quantitative Results

The integration of these advanced methods has yielded several critical insights into the biological and behavioral markers of psychiatric disorders:

Biochemical Predictors

A meta-analysis of 2,907 patients identified high homocysteine levels as an independent predictor for poststroke depression (PSD). Specifically, patients with the highest levels of this amino acid faced a 3.72 times higher risk of developing PSD compared to those with the lowest levels, suggesting a clear biochemical target for early screening.

Objective Behavioral Metrics

The introduction of the "Behavioral Depression Degree" (BDD), derived from AI-driven video analysis, offers a promising alternative to traditional scales. The BDD metric showed a high correlation (over 74%) with the Hamilton Depression Scale (HAMD), providing a continuous, objective way to track patient progress without relying solely on self-reporting.

Environmental and Contextual Factors

Research into legal settings demonstrated how emotional states are not isolated; the emotional demeanor of an authority figure, such as a judge, can trigger specific emotional responses like fear in defendants. This underscores the importance of considering external social contexts when analyzing affective disorders.

Future Directions and Clinical Translation

While these studies represent significant progress, the editorial acknowledges that the fundamental challenge of fully mapping the interaction between cognitive and affective states persists. Future research must focus on:

  1. Refining Data Fusion: Developing more robust ways to integrate disparate data types, such as combining microbiome profiles with real-time behavioral data.
  2. Clinical Implementation: Transitioning these AI models from research environments into clinical workflows to support physicians in early diagnosis and personalized treatment planning.
  3. Causal Discovery: Moving beyond statistical correlation to determine whether specific metabolic or behavioral patterns are causal drivers of the transition from affective distress to cognitive decline.

By bridging the gap between data science and clinical psychiatry, this volume paves the way for a more nuanced and objective understanding of the human mind.

Summary updated

Abstract

Omics-Volume II 15Cognitive disorders, such as amnesia, dementia, and delirium, form a category of psychiatric 16 disorders that primarily impede learning, memory, perception, and problem-solving. Simultaneously, 17 affective disorders, encompassing conditions like depression and bipolar disorder, represent another 18 set of psychiatric disorders. While these categories differ, they may present overlapping symptoms 19 and can even intertwine. For instance, recent research indicates that affective issues, such as 20 depression, could potentially heighten the risk of developing dementia. Although there have been 21significant advances in the realm of knowledge discovery regarding both cognitive and affective 22 disorders, the challenge of understanding the interaction between these two categories still persists. 23Fortunately, the rapid evolution of experimental technologies has granted researchers the ability to 24 acquire multi-modal or multi-omics data in individual studies. We wish to express our gratitude to all the authors who have contributed to this special issue, and we 99 greatly appreciate the time and effort invested by the reviewers. We also extend our thanks to the 100 editor-in-chief and the entire editorial team at Frontiers in Psychiatry for their consistent support 101 throughout this process. 102
BibTeX
@inproceedings{wang2023editorial,
  author = {Tao Wang and Elaine Chapman and zhongyu wei and Jiajie Peng},
  title = {{Editorial: Data mining methods for analyzing cognitive and affective disorders based on multimodal omics, volume II}},
  booktitle = {Frontiers in Psychiatry},
  year = {2023},
  doi = {10.3389/fpsyt.2023.1273351},
}
Figure